Position in EXEL
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$4,878,618
+$3,739,546 QoQ
Shares Held
89,664
+237.6% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#176
of 751 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Janney Montgomery Scott LLC holds $121,989,266 across 55 Biotechnology names. EXEL ranks #5 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
85,735 | $42,587,146 | |
| 2 | SPRY |
ARS Pharmaceuticals, Inc.
|
2,064,498 | $16,536,628 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
12,176 | $7,592,223 | |
| 4 | INCY |
Incyte Corp
|
52,727 | $5,977,132 | |
| 5 | EXEL |
Exelixis, Inc.
This page
|
89,664 | $4,878,618 | |
| 6 | ZVRA |
Zevra Therapeutics, Inc.
|
272,194 | $3,903,261 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
13,087 | $3,203,304 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
79,550 | $2,815,274 |
All Filings in EXEL
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,878,618 | 89,664 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $1,139,072 | 26,558 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $661,482 | 15,092 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,079,871 | 26,147 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $1,298,464 | 29,457 | Shares | Sole | 2025-07-17 | |
| 2025-03-31 | $1,394,763 | 37,778 | Shares | Sole | 2025-04-17 | |
| 2024-12-31 | $1,108,756 | 33,296 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $788,854 | 30,399 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,321,617 | 58,817 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $1,441,502 | 60,746 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $1,373,091 | 57,236 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $1,276,608 | 58,426 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $1,227,721 | 64,245 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $1,193,870 | 61,508 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $924,032 | 57,608 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $795,760 | 50,750 | Shares | Sole | 2022-10-25 | |
| 2022-06-30 | $1,141,165 | 54,811 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $1,354,804 | 59,762 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $1,070,019 | 58,535 | Shares | Sole | 2022-01-27 | |
| 2021-09-30 | $1,454,009 | 68,780 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $904,131 | 49,623 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,103,611 | 48,854 | Shares | Sole | 2021-04-27 | |
| No filing history on record for this holder in this stock. | ||||||